A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...